Media headlines about InfuSystem Holdings (NYSE:INFU) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. InfuSystem Holdings earned a coverage optimism score of 0.09 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 45.0498612579362 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of InfuSystem Holdings (NYSE INFU) remained flat at $2.10 during midday trading on Wednesday. The company’s stock had a trading volume of 1,771 shares. InfuSystem Holdings has a 52-week low of $1.20 and a 52-week high of $2.91. The stock’s market cap is $47.79 million. The firm’s 50 day moving average is $1.89 and its 200 day moving average is $1.89.

InfuSystem Holdings (NYSE:INFU) last issued its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter. InfuSystem Holdings had a negative return on equity of 9.02% and a negative net margin of 6.53%. The business had revenue of $16.94 million during the quarter. Equities analysts expect that InfuSystem Holdings will post $0.24 EPS for the current fiscal year.

In other news, Director Meridian Ohc Partners, Lp purchased 19,982 shares of the stock in a transaction on Monday, September 11th. The shares were acquired at an average price of $2.00 per share, for a total transaction of $39,964.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Darrell B. Montgomery purchased 25,000 shares of the stock in a transaction on Monday, August 14th. The shares were purchased at an average price of $1.88 per share, for a total transaction of $47,000.00. Following the transaction, the director now directly owns 12,000 shares of the company’s stock, valued at $22,560. The disclosure for this purchase can be found here. Insiders purchased 191,029 shares of company stock worth $360,262 in the last quarter.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Daily Political and is the property of of Daily Political. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at

About InfuSystem Holdings

InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.

Insider Buying and Selling by Quarter for InfuSystem Holdings (NYSE:INFU)

Receive News & Ratings for InfuSystem Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem Holdings Inc and related companies with's FREE daily email newsletter.